Major depressive disorder and treatment-resistant depression represent two of the most significant public health challenges of the modern era. Across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, millions of individuals navigate persistent low mood, emotional blunting, and cognitive exhaustion. Standard pharmacological interventions, such as selective […]